Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Cosmo Daisey who wrote (507)	5/4/1998 12:24:00 PM
From: OtherChap	Respond to of 2135

>If it works try over $5000 next year. you are forgetting one thing, if it turns out to really be a 100% cure for cancer, the US government wont let one company monopolize and profit insanely from it. plus, other countries that dont recognize US drug patents will clone it and sell the drugs at a huge discount.

To: Cosmo Daisey who wrote (507)	5/4/1998 1:15:00 PM
From: StockDoc	Read Replies (2) \| Respond to of 2135

All right Haolin and Cosmo, here's why I think this way. There are three important natural causes people die of: thrombosis (blood clots in the heart and brain), cancer and, still, bacterial infections. The biggest medical discovery of the first part of this century was the antibiotics. Although death from infections decreased from the first cause of death to the 4th, or so, we still need some, a discovery, something along a natural defense mechanism, to reduce pneumonia deaths. The biggest medical discovery of the second half of this century, I think, is the angiogenesis inhibitors and promoters, because they promise solutions to the two other major causes of death. If someone can solve at least cancer that person cannot be compared to other ordinary folks, as you did, Haolin. Averages don't apply to individuals. Some stock dips 90%. So others can jump 900% to make the average. I invested in ENMD (selected one company which I though was doing the best science), and I believe that if they don't dilute in 1 year, this stock will worth at least 100 (or more, as you said, Cosmo). Unless someone comes up with a pill. By the way, unlike big pharma, biotech is not unfamiliar with 700% increase. StockDoc